All articles tagged with #tylenol
A new Danish study suggests that maternal use of acetaminophen (Tylenol/paracetamol) during pregnancy may be associated with smaller ovaries, fewer ovarian follicles, and smaller uteruses in female infants. Researchers emphasize this is observational and does not prove causation or impact future fertility, while Kenvue maintains the drug remains the safest pain reliever for pregnant women.
A new study in Denmark found that girls exposed to acetaminophen in the womb had significantly smaller ovaries and uteruses at three months old. While experts warn this does not prove causation or impact future fertility, the findings have sparked debate about the drug's safety profile during pregnancy.
The FDA approved a non-prescription pill that combines 650 mg acetaminophen (Tylenol) with 220 mg naproxen sodium for adults and children 12 and older, offering up to 12 hours of relief for headaches, back pain, muscle aches, toothache, menstrual cramps, and minor arthritis pain. Developed by Kenvue, the pill is expected to be sold at major retailers and was supported by eight clinical studies showing superior relief compared to the individual drugs.
Health Secretary RFK Jr. attacked a Danish study in JAMA Pediatrics that found no link between prenatal acetaminophen (Tylenol) use and autism, calling the research “garbage” during a House Education and Workforce Committee hearing. He argued the study is flawed and should be retracted, while experts defended the methodology and cited prior research showing no increased autism risk from Tylenol exposure, including findings from a 2024 Swedish study; Kenvue did not comment."
A rigorous Lancet review of 43 studies found no association between acetaminophen (Tylenol) use during pregnancy and autism, ADHD, or intellectual disability, supporting Tylenol as a safe first-line treatment for pain/fever in pregnancy and countering earlier warnings tied to Trump-era statements. The analysis used strict study selection, quality assessment, and sibling comparison studies to rule out bias, though some experts noted previous conflicting findings and ongoing debates about confounding factors.
The FDA has issued a widespread recall of thousands of products, including Tylenol, Advil, Haribo candies, Welch's juice, and Purina pet food, due to contamination from rodent and bird droppings at a Minnesota distribution facility, posing health risks to consumers.
Recent scientific reviews find no conclusive evidence linking acetaminophen use during pregnancy to autism or ADHD, contradicting claims made by the Trump administration, which lacked robust data and faced international criticism for its stance.
Texas Attorney General Ken Paxton is seeking to block Tylenol maker Kenvue from paying $400 million in dividends amid a lawsuit claiming the company failed to disclose autism risks associated with the medication, using a rare legal move to protect potential assets for legal liabilities. The case is part of broader political and health debates surrounding Tylenol and autism, with the company denying the allegations and criticizing the lawsuit as politically motivated.
Texas Attorney General Ken Paxton has requested a federal judge to issue a restraining order against Tylenol's makers, Johnson & Johnson and Kenvue, to stop them from advertising the drug as safe for pregnant women and children, amid claims of deceptive marketing and conflicting health guidance from the FDA and presidential warnings.
The article discusses the safety and appropriate use of Tylenol for treating children's fevers, emphasizing that there is no credible evidence linking acetaminophen to autism and that it is safe when used correctly. It highlights the importance of managing fever based on the child's behavior and comfort, and clarifies that high fevers are not always dangerous if the child appears well.
Kimberly-Clark is acquiring Kenvue, the maker of Tylenol and other consumer health products, in a nearly $49 billion deal, aiming to create a global health and wellness leader amid challenges faced by Kenvue following controversial claims linking acetaminophen to autism.
Kimberly-Clark is acquiring Kenvue, the maker of Tylenol, for $40 billion, creating a leading health and wellness company with over $32 billion in revenue, despite legal and market challenges related to Tylenol's safety concerns and recent financial struggles of Kenvue.
Texas' attorney general sued Tylenol's makers, alleging deceptive marketing and knowing about a potential link between acetaminophen and autism, amid ongoing debates and legal battles over the safety of the painkiller during pregnancy.
Texas Attorney General Ken Paxton is suing Johnson & Johnson and Kenvue over claims that Tylenol is deceptively marketed as leading to autism, despite a lack of scientific evidence supporting this link. The lawsuit is based on tenuous associations and flawed studies, with experts noting no proven causal relationship between Tylenol and autism.
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging they concealed the potential link between Tylenol (acetaminophen) and autism/ADHD, despite government confirmation of risks and public warnings by Trump. Kenvue defends Tylenol's safety, while Johnson & Johnson disclaims liability, leading to stock declines for both companies.